Advent International LP -backed Svatantra Microfin Pvt. has met with bankers and lawyers as the first step in the process for an initial public offering that could raise as much as $250 million, according to people familiar with the matter. The firm, founded by Ananya Birla, daughter of billionaire Kumar Mangalam Birla , has hired Kotak Mahindra Capital Co. and Axis Capital Ltd. as advisers to the...
Advent International LP -backed Svatantra Microfin Pvt. has met with bankers and lawyers as the first step in the process for an initial public offering that could raise as much as $250 million, according to people familiar with the matter. The firm, founded by Ananya Birla, daughter of billionaire Kumar Mangalam Birla , has hired Kotak Mahindra Capital Co. and Axis Capital Ltd. as advisers to the potential share sale and likely to add more bankers later, the people said, asking not to be identified as the discussions are private. The company plans to file draft paperwork in the next few months, the people said. The offering is expected to comprise a mix of primary share issuance and secondary sales by existing investors, they added. Deliberations are ongoing and details, including the size of the offering, may change. Representatives for Svatantra Microfin and the banks didn’t immediately respond to requests for comment. Indian companies have raised about $2.9 billion through IPOs this year, compared with roughly $22 billion in all of 2025, according to data compiled by Bloomberg. Moneycontrol reported last month that Svatantra Microfin has appointed advisers for the proposed IPO. Global private equity firms Advent International and Multiples Private Equity invested about $230 million in Svatantra Microfin in 2024. Founded in 2012, Svatantra Microfin is India’s second-largest microfinance institution, according to its website . The company manages consolidated assets under management of about 220 billion rupees, with a network of more than 2,200 branches across 20 states and a workforce of about 25,000 employees, according to its website.
Supernus Pharmaceuticals ( SUPN ) has officially entered into an asset purchase agreement with Navitor Pharmaceuticals, Inc., and Navitor Pharmaceuticals, LLC. as of April 1, 2026. Supernus may pay up to $350 million in total, triggered by specific development, regulatory, and commercial achievements. This agreement follows a development and option agreement from April 21, 2020, and a binding memo...
Supernus Pharmaceuticals ( SUPN ) has officially entered into an asset purchase agreement with Navitor Pharmaceuticals, Inc., and Navitor Pharmaceuticals, LLC. as of April 1, 2026. Supernus may pay up to $350 million in total, triggered by specific development, regulatory, and commercial achievements. This agreement follows a development and option agreement from April 21, 2020, and a binding memorandum of understanding from May 5, 2025, between the company and Navitor. Under this agreement, Supernus will acquire various assets from the sellers, including intellectual property rights, inventory, regulatory and clinical materials, permits, data, records, certain contract rights, and related goodwill associated with the compound known as NV-5138 or SPN-820, termed the purchased assets. The purchase price includes Supernus's commitment to complete one Phase 2b study and to make milestone payments totaling up to $350M, contingent on achieving specific development, regulatory, and commercial milestones. The agreement also contains a five-year post-closing non-competition and non-solicitation covenant applicable to the restricted parties. The company must try its best to meet the milestones. If the Phase 2 Study is unsuccessful, the company is not obligated to continue with the milestones or commercialization of the compound. More on Supernus Pharmaceuticals Supernus Pharmaceuticals, Inc. (SUPN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Supernus Pharmaceuticals, Inc. (SUPN) Q4 2025 Earnings Call Transcript Supernus: Outlook For 2026 Positive, Upholding Buy Rating Supernus outlines $840M–$870M 2026 revenue target as ONAPGO supply normalizes and growth brands accelerate Supernus Pharmaceuticals GAAP EPS of $0.07 beats by $0.28, revenue of $211.6M beats by $16.44M
JHVEPhoto/iStock Editorial via Getty Images Amid this year's flight to safety in the stock markets, the safest bet in the tech sector has emerged as chip stocks . After all, most chip manufacturers (especially memory companies) are sold out, thanks to the data center boom. That guarantee of solid revenue growth throughout the next few years has caused a skyrocketing in the semiconductor industry, ...
JHVEPhoto/iStock Editorial via Getty Images Amid this year's flight to safety in the stock markets, the safest bet in the tech sector has emerged as chip stocks . After all, most chip manufacturers (especially memory companies) are sold out, thanks to the data center boom. That guarantee of solid revenue growth throughout the next few years has caused a skyrocketing in the semiconductor industry, leaving most companies to be incredibly overvalued. To me, there is one exception: Micron ( MU ), who, alongside Samsung, SK Hynix, and Western Digital ( WDC ), are the world's suppliers of NAND memory. Shares of Micron have leaped ~5x over the past year, but the stock is down ~20% since reporting Q2 results in mid-March. In my view, the market's recent profit-taking is a great time to add this stock on recent weakness. Data by YCharts I last wrote a "Buy" article on Micron in January, when the stock was trading in the $340s. Since then, Micron briefly spiked to above $460 and has quickly ratcheted down since the company's mid-March earnings release, which I view to be a "buy the rumor, sell the news" pattern on very strong fiscal Q2 (February quarter) results. With an opportunity to buy Micron on this breather, I'm reiterating my "Buy" rating here. Strong Near-Term Demand Coupled With Longer-Term Contracts It's impossible to discuss Micron without immediately addressing the company's sharp revenue growth rates, which underscore how rampant demand is for its memory chips. The chart below showcases Micron's revenue by business unit: Micron revenue trends (Micron Q2 earnings deck) Overall, Micron's total revenue of $23.86 billion increased by a whopping 196% y/y, or tripled y/y. Even though supply is constrained (and as such, Micron itself should have high visibility into what its near-term revenue should be), Micron beat Wall Street's revenue expectations of $19.76 billion (+145% y/y) by a wide margin. What we are most interested in dissecting, however, is the fact that Micr...
JHVEPhoto/iStock Editorial via Getty Images Amid this year's flight to safety in the stock markets, the safest bet in the tech sector has emerged as chip stocks . After all, most chip manufacturers (especially memory companies) are sold out, thanks to the data center boom. That guarantee of solid revenue growth throughout the next few years has caused a skyrocketing in the semiconductor industry, ...
JHVEPhoto/iStock Editorial via Getty Images Amid this year's flight to safety in the stock markets, the safest bet in the tech sector has emerged as chip stocks . After all, most chip manufacturers (especially memory companies) are sold out, thanks to the data center boom. That guarantee of solid revenue growth throughout the next few years has caused a skyrocketing in the semiconductor industry, leaving most companies to be incredibly overvalued. To me, there is one exception: Micron ( MU ), who, alongside Samsung, SK Hynix, and Western Digital ( WDC ), are the world's suppliers of NAND memory. Shares of Micron have leaped ~5x over the past year, but the stock is down ~20% since reporting Q2 results in mid-March. In my view, the market's recent profit-taking is a great time to add this stock on recent weakness. Data by YCharts I last wrote a "Buy" article on Micron in January, when the stock was trading in the $340s. Since then, Micron briefly spiked to above $460 and has quickly ratcheted down since the company's mid-March earnings release, which I view to be a "buy the rumor, sell the news" pattern on very strong fiscal Q2 (February quarter) results. With an opportunity to buy Micron on this breather, I'm reiterating my "Buy" rating here. Strong Near-Term Demand Coupled With Longer-Term Contracts It's impossible to discuss Micron without immediately addressing the company's sharp revenue growth rates, which underscore how rampant demand is for its memory chips. The chart below showcases Micron's revenue by business unit: Micron revenue trends (Micron Q2 earnings deck) Overall, Micron's total revenue of $23.86 billion increased by a whopping 196% y/y, or tripled y/y. Even though supply is constrained (and as such, Micron itself should have high visibility into what its near-term revenue should be), Micron beat Wall Street's revenue expectations of $19.76 billion (+145% y/y) by a wide margin. What we are most interested in dissecting, however, is the fact that Micr...
W1A’s bumbling head of BBC values is back – this time as head of integrity on the World Cup team. Plus: new thriller, The Copenhagen Test. Here’s what to watch this evening 10pm, BBC Two Is the mood music around this summer’s World Cup compatible with a sitcom? After all, the main host nation is threatening to turn the event into an apocalyptic drama. Enter bumbling Ian Fletcher (Hugh Bonneville) ...
W1A’s bumbling head of BBC values is back – this time as head of integrity on the World Cup team. Plus: new thriller, The Copenhagen Test. Here’s what to watch this evening 10pm, BBC Two Is the mood music around this summer’s World Cup compatible with a sitcom? After all, the main host nation is threatening to turn the event into an apocalyptic drama. Enter bumbling Ian Fletcher (Hugh Bonneville) in his new role as director of integrity for a (redacted) sporting body, whose relationship with the concept is already a punchline. While the tone is subtly different from that of W1A and Twenty Twelve – in those shows, no one really said anything; here, everyone shouts at once – the satirical intent is similar. David Tennant’s narration adds a satisfying extra layer of snark as issues of staging and environmental impact are tossed into the corporate meat grinder. Phil Harrison Continue reading...
Zhipu raised the cost of access to its most advanced AI model by at least 8%, joining other leading Chinese artificial intelligence players in trying to profit off years of research and computing investments. The Beijing-headquartered company released its latest open source model GLM-5.1 this week. It set prices for cloud-based usage — for instance, input tokens — between 8% and 17% higher roughly...
Zhipu raised the cost of access to its most advanced AI model by at least 8%, joining other leading Chinese artificial intelligence players in trying to profit off years of research and computing investments. The Beijing-headquartered company released its latest open source model GLM-5.1 this week. It set prices for cloud-based usage — for instance, input tokens — between 8% and 17% higher roughly than for its older GLM-5 Turbo, according to official pricing on OpenRouter. That’s at least the second time the company, which debuted in Hong Kong in January, has raised prices for users in 2026. Zhipu joins rivals from Alibaba Group Holding Ltd. to Tencent Holdings Ltd. in jacking up charges, responding to surging demand for OpenClaw-like agentic services as well as pressure from investors to begin delivering on profits. The increase followed a 30% price hike of its coding plan in February. The company last month reported a wider loss of 4.7 billion yuan ($688 million) for 2025, but its shares surged as much as 35% with investors upbeat about the prospects for monetization. The stock was up more than 18% Wednesday, buoyed by a broad-based regional rally. Read More: Zhipu Gains $14 Billion Value After AI Fever Overrides Big Loss Chief Executive Officer Zhang Peng said during a post-earnings call that he expected “exponential growth” for his firm’s cloud-based models business. Zhipu, also known as Z.ai, has been releasing new models at an accelerated speed to compete with US rivals like Anthropic and OpenAI as well as domestic peers such as DeepSeek . The latest release, GLM-5.1, comes with major upgrades in coding and long-horizon tasks. It can run autonomously for eight hours, Zhipu said in a statement. The new model’s coding performance nears Anthropic’s Claude Opus 4.6, it added. Read More: China Becomes Agentic AI’s Biggest Lab With OpenClaw Stampede